Showing results (1-10 of 178) with videos related to
Sort By:
Pageof 18
Biorxiv : the Preprint Server for Biology|February 6, 2026
mRNA Therapy for Alport SyndromeBrian J Parrett, Michael A BarryMolecular Therapy. Methods & Clinical Development|January 27, 2025
Reducing off-target expression of mRNA therapeutics and vaccines in the liver with microRNA binding sitesBrian J Parrett, Satoko Yamaoka, Michael A BarryMolecular Therapy. Nucleic Acids|October 27, 2025
Infection-sensing minigenome as a novel therapeutic approach against Ebola virusLin Wang, Brady N Zell, Brian J Parrett, et al.Human Gene Therapy|November 3, 2021
Modulating Oncolytic Adenovirus Immunotherapy by Driving Two Axes of the Immune System by Expressing 4-1BBL and CD40LShao-Chia Lu, Michael J Hansen, Jack R Hemsath, et al.Vaccines|February 26, 2026
Comparison of Immune Cell Transfection by Different Vaccine Vectors After Intradermal InjectionJiani Liu, Destin T Hinson, Michael J Hansen, et al.American Journal of Respiratory Cell and Molecular Biology|October 14, 2025
Lung-targeted Lipid Nanoparticle Delivery of a Matricellular mRNA Promotes Fibrotic Lung RepairKalpana R Betageri, Jeffrey A Meridew, Brian J Parrett, et al.Journal of Virology|November 17, 2021
Ex Vivo and In Vivo CD46 Receptor Utilization by Species D Human Adenovirus Serotype 26 (HAdV26)Jack R Hemsath, A Manuel Liaci, Jeffrey D Rubin, et al.Journal of Virology|October 18, 2005
Selection of muscle-binding peptides from context-specific peptide-presenting phage libraries for adenoviral vector targetingDebadyuti Ghosh, Michael A BarryHuman Gene Therapy|December 22, 2004
Rapid construction of capsid-modified adenoviral vectors through bacteriophage lambda Red recombinationSamuel K Campos, Michael A BarryVirology|March 1, 2006
Comparison of adenovirus fiber, protein IX, and hexon capsomeres as scaffolds for vector purification and cell targetingSamuel K Campos, Michael A BarryPageof 18